1. We have audited the accompanying financial statementsof Jagsonpal Pharmaceuticals Limited ('the Company'),which comprise the Balance Sheet as at 31 March 2025,the Statement of Profit and Loss (including OtherComprehensive Income), the Statement of Cash Flowand the Statement of Changes in Equity for the yearthen ended, and notes to the financial statements,including material accounting policy information andother explanatory information.
2. In our opinion and to the best of our information andaccording to the explanations given to us, the aforesaidfinancial statements give the information required bythe Companies Act, 2013 ('the Act') in the manner sorequired and give a true and fair view in conformity withthe Indian Accounting Standards ('Ind AS') specifiedunder section 133 of the Act read with the Companies(Indian Accounting Standards) Rules, 2015 and otheraccounting principles generally accepted in India, of thestate of affairs of the Company as at 31 March 2025, andits profit (including other comprehensive income), itscash flows and the changes in equity for the year endedon that date.
3. We conducted our audit in accordance with theStandards on Auditing specified under section 143(10)of the Act. Our responsibilities under those standardsare further described in the Auditor's Responsibilitiesfor the Audit of the Financial Statements section ofour report. We are independent of the Company inaccordance with the Code of Ethics issued by the Instituteof Chartered Accountants of India ('ICAI') together withthe ethical requirements that are relevant to our auditof the financial statements under the provisions of theAct and the rules thereunder, and we have fulfilled ourother ethical responsibilities in accordance with theserequirements and the Code of Ethics. We believe thatthe audit evidence we have obtained is sufficient andappropriate to provide a basis for our opinion.
4. Key audit matters are those matters that, in ourprofessional judgment, were of most significance inour audit of the financial statements of the currentperiod. These matters were addressed in the contextof our audit of the financial statements as a whole, andin forming our opinion thereon, and we do not providea separate opinion on these matters.
5. We have determined the matters described below to bethe key audit matters to be communicated in our report.
Key audit matters
How our audit addressed the key audit matters
Revenue from sale of products:
Our audit procedures in relation to revenue from sale of
Refer notes 2(d)(vii) and 21 to the financial statements for
products included, but were not limited to the following:
material accounting policy information and revenue related
- Obtained understanding of the revenue business processes
disclosures respectively.
of the Company;
The Company recognises revenue from the sale of
- Assessed the appropriateness of revenue recognition
pharmaceutical products when control of such products is
policy of the Company in accordance with Ind AS 115;
transferred to the customer and there are no longer any
- Involved our IT specialists to evaluate the design and test
unfulfilled obligations. Revenue towards a performanceobligation is measured at the amount of transaction priceallocated to that performance obligation and is accountedfor net of rebates or discounts.
operating effectiveness of IT general controls and keyautomated controls of the Company's IT system which isused for revenue recognition;
- Evaluated the design and tested the operating effectiveness
The Company has a large number of customers operating in
of key manual controls over revenue recognition;
various geographies throughout the country and the salescontracts / arrangements with such customers have distinct
- Performed substantive analytical procedures which
/ varying commercial terms. Accordingly, the Application/applicability. of Ind AS 115, Revenue from Contractswith Customers ('Ind AS 115') requires management to
includes margin analysis and period-on-period varianceanalysis on revenue recognised during the year to identifyany unusual indicators/trends;
make certain judgement / estimates such as determining
- Performed test of details by selecting samples of revenue
timing of transfer of control for revenue recognition and
transactions pertaining to sale of products recorded during
determining transaction price as per the terms of the
the year and verified the underlying supporting documents
contracts and arrangements.
including contracts / agreements, sales invoices, proofs of
Further, the Company considers revenue as a key
dispatch and delivery etc.;
benchmark for evaluating performances and hence, there is
- Performed testing by selecting samples pertaining to
risk of revenue being overstated due to pressure to achieve
revenue transactions recorded during specific period
targets and earning expectations and therefore, in line with
before the year end and after the year end to ensure
the requirements of the Standards on Auditing, revenue is
revenue from such transactions is recorded in the correct
determined to be an area involving significant risk which
period;
requires significant auditor attention.
Owing to the amounts involved, volume of salestransactions, distinct/varied terms of contracts withcustomers and above-mentioned judgement /estimates,revenue from sale of products has been considered as akey audit matter for current year audit.
- Obtained management workings for amounts recognisedtowards rebates/discounts and returns during theyear and as at year end. On a sample basis, tested theunderlying calculations for amounts recorded as accrualsand provisions towards the aforementioned obligations,as per the terms of related contracts and regulations, andtraced the underlying data to source documents; and
- Evaluated the appropriateness and adequacy of therelated presentation and disclosures made in the financialstatements in accordance with the requirements ofapplicable accounting standards
Business combination
Refer to Note 2(d)(iv) and 44 to the financial statementsfor material accounting policy information and businesscombination related disclosure respectively.
During the current year, the Company entered into abusiness transfer agreement and acquired the businessof dermatology and childcare divisions of Yash PharmaLaboratories Private Limited.
The Company has determined the aforesaid acquisitionto be a business and has accounted this acquisition usingthe acquisition method of accounting in accordance withInd AS 103 'Business Combinations' ('Ind AS 103'), whichrequires the identified assets and liabilities to be recognisedat fair value at the date of acquisition, with the excess ofthe purchase consideration over the fair value of identifiedassets and liabilities as goodwill.
Pursuant to the acquisition, the Company has acquired andaccounted for identifiable intangible assets amounting toINR 823.04 million, mainly comprising brands, technicalknow-how and non-compete right and goodwill of INR96.93 million at the date of acquisition representing asignificant portion of the purchase price being attributableto aforesaid assets.
The Company has appointed an external valuation expertto perform valuation of assets/liabilities for the purpose ofallocation of the purchase price to the identified assets andliabilities including identified intangible assets acquiredusing various valuation models adopted by the expert,which involved significant judgements and estimatesincluding the method used, future projections, relevantgrowth rates and the discount rate.
Considering the significance of the acquisition to theoverall financial statement, the significant judgementand estimates involved and the significant auditorattention required to test such management judgementand estimates, the accounting and valuation of aforesaidbusiness combination has been considered as a key auditmatter for the current year audit.
6. The Company's Board of Directors are responsiblfor the other information. The other informatiocomprises the information included in the AnnuaReport, but does not include the financial statementand our auditor's report thereon. The Annual Report iexpected to be made available to us after the date othis auditor's report.
Our opinion on the financial statements does not covethe other information and we do not express any fornof assurance conclusion thereon.
Our audit procedures with respect to said business combination
included, but were not limited to, the following:
- Obtained an understanding from the management withrespect to business combination process and assessedthe appropriateness of the Company's accounting policyrelated to business combination in accordance with Ind AS103;
- Evaluated the design and tested the operating effectivenessof the key controls over the accounting of businesscombination which includes valuation of identified assetsand liabilities acquired under the business combination;
- Obtained an understanding of the terms of agreementsentered by the Company for the said acquisition toevaluate management's assessments towards control overthe business and the acquisition date in accordance withInd AS 103;
- Obtained management's external valuation expert's reporton purpose price allocation and evaluated the competence,capabilities and objectivity of management's expert;
- Involved auditor's valuation expert to assist us in evaluatingthe appropriateness of the valuation models and thereasonableness of underlying key assumptions used bymanagement's expert in determining the fair value ofidentified assets and liabilities as at the acquisition date;
- Assessed the reasonableness of assumptions used andtested the projections included in the valuation modelsbased on our understanding of the business and marketconditions, with specific attention to inputs involvingestimation and judgement, as identified by performingsensitivity analysis;
- Tested the arithmetical accuracy of management'scomputations and valuation model; and
- Evaluated the adequacy and appropriateness of thedisclosures made in the financial statements in accordancewith applicable accounting standards.
In connection with our audit of the financial statements,our responsibility is to read the other informationidentified above when it becomes available and, indoing so, consider whether the other information ismaterially inconsistent with the financial statementsor our knowledge obtained in the audit or otherwiseappears to be materially misstated.
When we read the Annual Report, if we concludethat there is a material misstatement therein, we arerequired to communicate the matter to those chargedwith governance.
7. The accompanying financial statements have beenapproved by the Company's Board of Directors. TheCompany's Board of Directors are responsible forthe matters stated in section 134(5) of the Act withrespect to the preparation and presentation of thesefinancial statements that give a true and fair view ofthe financial position, financial performance includingother comprehensive income, changes in equity andcash flows of the Company in accordance with theInd AS specified under section 133 of the Act andother accounting principles generally accepted inIndia. This responsibility also includes maintenance ofadequate accounting records in accordance with theprovisions of the Act for safeguarding of the assets ofthe Company and for preventing and detecting fraudsand other irregularities; selection and application ofappropriate accounting policies; making judgments andestimates that are reasonable and prudent; and design,implementation and maintenance of adequate internalfinancial controls, that were operating effectivelyfor ensuring the accuracy and completeness of theaccounting records, relevant to the preparation andpresentation of the financial statements that give a trueand fair view and are free from material misstatement,whether due to fraud or error.
8. In preparing the financial statements, the Board ofDirectors is responsible for assessing the Company'sability to continue as a going concern, disclosing, asapplicable, matters related to going concern and usingthe going concern basis of accounting unless the Boardof Directors either intends to liquidate the Company orto cease operations, or has no realistic alternative butto do so.
9. The Board of Directors is also responsible for overseeingthe Company's financial reporting process.
10. Our objectives are to obtain reasonable assuranceabout whether the financial statements as a wholeare free from material misstatement, whether dueto fraud or error, and to issue an auditor's reportthat includes our opinion. Reasonable assurance is ahigh level of assurance, but is not a guarantee thatan audit conducted in accordance with Standards onAuditing will always detect a material misstatementwhen it exists. Misstatements can arise from fraud orerror and are considered material if, individually or inthe aggregate, they could reasonably be expected toinfluence the economic decisions of users taken on thebasis of these financial statements.
11. As part of an audit in accordance with Standards onAuditing, specified under section 143(10) of the Actwe exercise professional judgment and maintainprofessional skepticism throughout the audit. We also:
• Identify and assess the risks of materialmisstatement of the financial statements, whetherdue to fraud or error, design and perform auditprocedures responsive to those risks, and obtainaudit evidence that is sufficient and appropriateto provide a basis for our opinion. The risk of notdetecting a material misstatement resulting fromfraud is higher than for one resulting from error,as fraud may involve collusion, forgery, intentionalomissions, misrepresentations, or the override ofinternal control;
• Obtain an understanding of internal control relevantto the audit in order to design audit proceduresthat are appropriate in the circumstances. Undersection 143(3)(i) of the Act we are also responsiblefor expressing our opinion on whether theCompany has adequate internal financial controlswith reference to financial statements in place andthe operating effectiveness of such controls;
• Evaluate the appropriateness of accountingpolicies used and the reasonableness ofaccounting estimates and related disclosuresmade by management;
• Conclude on the appropriateness of Board ofDirectors' use of the going concern basis ofaccounting and, based on the audit evidenceobtained, whether a material uncertainty existsrelated to events or conditions that may castsignificant doubt on the Company's ability tocontinue as a going concern. If we conclude thata material uncertainty exists, we are requiredto draw attention in our auditor's report to therelated disclosures in the financial statements or,if such disclosures are inadequate, to modify ouropinion. Our conclusions are based on the auditevidence obtained up to the date of our auditor'sreport. However, future events or conditions maycause the Company to cease to continue as agoing concern; and
• Evaluate the overall presentation, structure andcontent of the financial statements, including thedisclosures, and whether the financial statementsrepresent the underlying transactions and eventsin a manner that achieves fair presentation.
12. We communicate with those charged with governanceregarding, among other matters, the planned scopeand timing of the audit and significant audit findings,including any significant deficiencies in internal controlthat we identify during our audit.
13. We also provide those charged with governance witha statement that we have complied with relevantethical requirements regarding independence, andto communicate with them all relationships andother matters that may reasonably be thought tobear on our independence, and where applicable,related safeguards.
14. From the matters communicated with those chargedwith governance, we determine those matters that
were of most significance in the audit of the financialstatements of the current period and are thereforethe key audit matters. We describe these matters inour auditor's report unless law or regulation precludespublic disclosure about the matter or when, in extremelyrare circumstances, we determine that a matter shouldnot be communicated in our report because theadverse consequences of doing so would reasonablybe expected to outweigh the public interest benefitsof such communication.
15. As required by section 197(16) of the Act, basedon our audit, we report that the Company has paidremuneration to its directors during the year inaccordance with the provisions of and limits laid downunder section 197 read with Schedule V to the Act.
16. As required by the Companies (Auditor's Report) Order,2020 ('the Order') issued by the Central Government ofIndia in terms of section 143(11) of the Act we give inthe Annexure I a statement on the matters specified inparagraphs 3 and 4 of the Order, to the extent applicable.
17. Further to our comments in Annexure I, as required bysection 143(3) of the Act based on our audit, we report,to the extent applicable, that:
a) We have sought and obtained all the informationand explanations which to the best of ourknowledge and belief were necessary for thepurpose of our audit of the accompanyingfinancial statements;
b) Except for the matters stated in paragraph 17(h)(vi) below on reporting under Rule 11(g) of theCompanies (Audit and Auditors) Rules, 2014(as amended), in our opinion, proper books ofaccount as required by law have been kept by theCompany so far as it appears from our examinationof those books. Further, the back-up of the booksof accounts and other books and papers for oneof the software of the Company maintained inelectronic mode has not been maintained onservers physically located in India, on a daily basis;
c) The financial statements dealt with by this reportare in agreement with the books of account;
d) In our opinion, the aforesaid financial statementscomply with Ind AS specified under section 133 ofthe Act;
e) On the basis of the written representationsreceived from the directors and taken on recordby the Board of Directors, none of the directorsis disqualified as on 31 March 2025 from beingappointed as a director in terms of section 164(2)of the Act;
f) The modification relating to the maintenance ofaccounts and other matters connected therewithare as stated in paragraph 17(b) above on reportingunder section 143(3)(b) of the Act and paragraph17h(vi) below on reporting under Rule 11(g) of the
Companies (Audit and Auditors) Rules, 2014 (asamended);
g) With respect to the adequacy of the internalfinancial controls with reference to financialstatements of the Company as on 31 March 2025and the operating effectiveness of such controls,refer to our separate report in Annexure II whereinwe have expressed an unmodified opinion; and
h) With respect to the other matters to be includedin the Auditor's Report in accordance with rule 11of the Companies (Audit and Auditors) Rules, 2014(as amended), in our opinion and to the best ofour information and according to the explanationsgiven to us:
i. the Company, as detailed in note 38 to thefinancial statements, has disclosed the impactof pending litigations on its financial positionas at 31 March 2025;
ii. the Company did not have any long-termcontracts including derivative contracts forwhich there were any material foreseeablelosses as at 31 March 2025;
iii. there were no amounts which were requiredto be transferred to the Investor Educationand Protection Fund by the Company duringthe year ended 31 March 2025;
iv. (a) The management has represented that,
to the best of its knowledge and belief,as disclosed in note 45(i) to the financialstatements, no funds have beenadvanced or loaned or invested (eitherfrom borrowed funds or securitiespremium or any other sources or kindof funds) by the Company to or in anyperson(s) or entity(ies), including foreignentities ('the intermediaries'), withthe understanding, whether recordedin writing or otherwise, that theintermediary shall, whether, directly orindirectly lend or invest in other personsor entities identified in any mannerwhatsoever by or on behalf of theCompany ('the Ultimate Beneficiaries')or provide any guarantee, security or thelike on behalf the Ultimate Beneficiaries;
(b) The management has representedthat, to the best of its knowledge andbelief, as disclosed in note 45(ii) to thefinancial statements, no funds havebeen received by the Company from anyperson(s) or entity(ies), including foreignentities ('the Funding Parties'), with theunderstanding, whether recorded inwriting or otherwise, that the Companyshall, whether directly or indirectly, lendor invest in other persons or entitiesidentified in any manner whatsoeverby or on behalf of the Funding Party
('Ultimate Beneficiaries') or provide anyguarantee, security or the like on behalfof the Ultimate Beneficiaries; and
(c) Based on such audit proceduresperformed as considered reasonableand appropriate in the circumstances,nothing has come to our notice thathas caused us to believe that themanagement representations undersub-clauses (a) and (b) above containany material misstatement.
v. The final dividend paid by the Companyduring the year ended 31 March 2025 inrespect of such dividend declared for theprevious year is in accordance with section123 of the Act to the extent it applies topayment of dividend. Further as stated innote 35(b) to the accompanying financialstatements, the Board of Directors of theCompany have proposed final dividendfor the year ended 31 March 2025 which issubject to the approval of the members atthe ensuing Annual General Meeting. Thedividend declared is in accordance withsection 123 of the Act to the extent it appliesto declaration of dividend; and
vi. As stated in Note 46 to the financialstatements and based on our examinationwhich included test checks, the Company,in respect of financial year commencingon 1 April 2024, has used an accounting
software for maintaining its books of accountwhich has a feature of recording audit trail(edit log) facility and the same has beenoperated throughout the year for all relevanttransactions recorded in the software exceptthat the audit trail feature at the databaselevel was enabled only for certain key users tolog any direct data changes in the accountingsoftware. Further, during the course of ouraudit we did not come across any instanceof audit trail feature being tampered with,other than the consequential impact ofthe exception given above. Furthermore,other than the consequential impact of theexception given above the audit trail hasbeen preserved by the Company as per thestatutory requirements for record retentionfrom the date audit trail was enabled.
For Walker Chandiok & Co LLP
Chartered AccountantsFirm's Registration No.: 001076N/N500013
Madhu Sudan Malpani
Partner
Membership No.: 517440UDIN: 25517440BMLKDH6624
Place: GurugramDate: 06 May 2025